What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Action Timeline
2026-04-14
Referred to the House Committee on Education and Workforce.
2026-04-14
Introduced in House
2026-04-14
Introduced in House
Frequently Asked Questions
Did HR.8279 pass?
HR.8279 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.8279?
HR.8279 was sponsored by Thomas R. Suozzi (D-New York).
Full Bill Text
119 HR 8279 IH: To expand the definition of institution of higher education in the Higher Education Act of 1965 with respect to certain graduate medical schools located outside of the United States. U.S. House of Representatives 2026-04-14 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 2d Session H. R. 8279 IN THE HOUSE OF REPRESENTATIVES April 14, 2026 Mr. Suozzi introduced the following bill; which was referred to the Committee on Education and Workforce A BILL To expand the definition of institution of higher education in the Higher Education Act of 1965 with respect to certain graduate medical schools located outside of the United States. 1. Graduate medical schools outside of the United States Section 102(a)(2)(A) of the Higher Education Act of 1965 ( 20 U.S.C. 1002(a)(2)(A) ) is amended— (1) in the matter preceding clause (i), by striking graduate medical school, and inserting graduate medical school other than a graduate medical school described in clause (i)(I)(aa)(BB), a ; and (2) by amending item (aa) of clause (i)(I) to read as follows: (aa) (AA) at least 60 percent of those enrolled in, and at least 60 percent of the graduates of, the graduate medical school outside the United States were not persons described in section 484(a)(5) in the year preceding the year for which a student is seeking a loan under part D of title IV; or (BB) the school has or had a clinical training program that, as of January 31, 2021, was approved by a State with an approval process that required an on-site visit to the institution and its affiliated locations by that State or its authorized representatives, and that continues to operate a clinical training program in at least one State that is approved by that State; and .
Loading intelligence layer…